H3 symposium: Purinergic signalling in obesity and renal pathophysiology

22 January 2018

etc.venues - The Hatton,
51-53 Hatton Garden,
London EC1N 8HN, United Kingdom

Purinergic signalling mediated by extracellular nucleotides and nucleosides is at the forefront of research on pathophysiology of obesity and the kidney diseases. Obesity and kidney diseases have reached epidemic proportions throughout the world, affecting both developed and developing countries. Purinergic signalling offers the prospects of an entirely new class of drugs for the treatment of these conditions. This symposium will bring together researchers studying the role of purinergic signalling in obesity and renal pathophysiology. 

Purinergic signalling

  • Registration is open. Click here.
  • Abstract submission is open. Click here to submit.

The main aim of this symposium is to present state-of-the-art information and developments in the field. The justification for this symposium is: i) the timeliness of the topic and its relevance to physiology and pathophysiology of obesity and the kidney, ii) clinical significance of the pathophysiological conditions being presented, with a potential possibility for new drug development, and iii) worldwide prevalence of obesity and kidney diseases.

This symposium will present state-of-the-art information and knowledge in the following areas of purinergic signalling: (i) obesity and insulin resistance, specifically dealing with the role of hypothalamic UDP and P2Y2 receptor and adenosine signalling in diabetes mellitus and its complications; (ii) renal pathophysiology in relation to CD39-adenosinergic axis; and (iii) role of P2X receptors in mechanotransduction in podocytes and vasculature and inflammation, urinary tract infections, and medullary blood flow. At the end, there will be an open discussion moderated by an eminent investigator in the field. In addition, there will be free communications and poster presentations. 
 
The target audience includes academic researchers and clinicians working on obesity and insulin resistance and kidney diseases. This pertains to researchers at all levels from fellows to professors. They will hear and be able to engage with the current key figures and future leaders and have interactive time with them during the poster sessions as well as in lunch and coffee/tea breaks. We encourage non-speaking attendees to present posters. There will be prizes for best poster presentations. 

Organized by Bellamkonda Kishore, University of Utah Health & VA Medical Center, Salt Lake City, Utah, USA and Helle Prætorius, Aarhus University, Aarhus, Denmark

Confirmed speakers:

  • Mattias Carlström, Karolinska Institutet, Sweden
  • Carolyn Ecelbarger, Georgetown University , USA
  • Robert Menzies , University of Edinburgh, UK
  • Clair Peppiatt-Wildman, University of Kent, UK
  • Simon Robson, Beth Israel Deaconess Medical Center, Harvard University, USA
  • Sophie Steculorum, CECAD Research Center, University of Cologne, Germany
  • Ursula Storch, Ludwig Maximilians University of Munich, Germany